5 studies found for:    10561185 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Recruiting BENdamustine at Elevated Dose for Relapsed Follicular Lymphoma in Intensification Therapy and Transplantation (BENEFIT)
Condition: Follicular Lymphoma
Intervention: Drug: BeEAM
2 Recruiting Phase 1/2 Clinical Trial of NPI-0052 in Patients With Relapsed or Relapsed/Refractory Multiple Myeloma
Condition: Multiple Myeloma
Intervention: Drug: NPI-0052
3 Completed External Beam Radiotherapy and Zevalin for Management of Indolent B-Cell Non-Hodgkin's Lymphoma
Condition: Lymphoma, B-Cell
Intervention: Other: external beam radiotherapy plus 90-Y ibritumomab tiuxetan
4 Completed A Phase II Trial of Combined Weekly Bortezomib and Tositumomab I-131 in Patients With Relapsed or Refractory Follicular Non-Hodgkin's Lymphoma
Condition: Follicular Lymphoma
Intervention: Drug: Bortezomib and Tositumomab I-131
5 Terminated Study of MK 2206 in Patients With Relapsed or Refractory Diffuse Large B Cell Lymphoma
Condition: Diffuse Large B Cell Lymphoma
Intervention: Drug: MK2206

Indicates status has not been verified in more than two years